AI Chatbots for Depression: What Does the Evidence Show?

✓ Medically reviewed | Published: | Evidence level: 1A
A review of 48 randomized trials reports modest improvements in depression, anxiety and stress with conversational agents. The findings concern studied interventions and do not establish that any chatbot can deliver effective therapy.
📅 Published:
✓ Reviewed by iMedic Medical Editorial Team
📄 Mental Health

Quick Facts

Trials Reviewed
48 randomized trials
Total Participants
28,071 people
Outcomes Assessed
3 symptom domains

How much can conversational agents improve mental health symptoms?

Quick answer: The pooled results suggest small average improvements, with greater uncertainty around anxiety outcomes.

The systematic review, published in npj Digital Medicine on May 29, 2026, found standardized mean differences of −0.27 for depression, −0.20 for anxiety and −0.26 for stress. These measure differences between intervention and comparison groups on a common scale; they are not percentage reductions or recovery rates. [Read the meta-analysis](https://www.nature.com/articles/s41746-026-02820-1).

Evidence certainty was moderate for depression and stress but low for anxiety, partly because of possible publication bias. Long-term benefit remains uncertain. Both scripted and AI-based systems were included, so the findings should not be generalized to every contemporary generative chatbot. [Study findings and limitations](https://www.nature.com/articles/s41746-026-02820-1).

How might a mental health chatbot help someone feel better?

Quick answer: A structured digital intervention can help people practice psychological skills and monitor their progress.

Cognitive behavioral therapy, or CBT, helps people recognize unhelpful interpretations, examine the evidence behind them and change behaviors that reinforce distress. For example, someone who interprets a setback as proof of personal failure might practice developing a more balanced explanation. The National Institute of Mental Health describes these techniques as components of established psychotherapy. Delivering an exercise through software changes its format; the underlying therapeutic skill still matters. [NIMH guidance on psychotherapy](https://www.nimh.nih.gov/health/topics/psychotherapies).

Digital tools can also support practice between appointments, offer coping exercises and help users record symptoms. Their practical appeal includes access outside clinic hours and reduced travel demands. NIMH emphasizes that engagement matters: an intervention has limited opportunity to help if people stop using it. A reasonable interpretation is that useful therapeutic content and sustained participation deserve attention alongside how naturally a chatbot converses. [NIMH overview of mental health technology](https://www.nimh.nih.gov/health/topics/technology-and-the-future-of-mental-health-treatment).

What should patients look for before using a mental health chatbot?

Quick answer: Look for evidence about the specific product, clear privacy information and a route to professional support.

A claim that an app uses CBT does not demonstrate that the complete product has been tested successfully. NIMH recommends examining supporting research, considering the developer's qualifications and checking what help is available if symptoms worsen. Discussing an app with a clinician can help establish whether it fits an existing care plan. The relevant question is whether the particular intervention helps people with comparable needs. [NIMH advice on evaluating mental health apps](https://www.nimh.nih.gov/health/topics/technology-and-the-future-of-mental-health-treatment).

Generative systems introduce additional concerns because fluent responses can contain incorrect or biased information. The World Health Organization also identifies excessive trust in automated outputs and risks to sensitive health data. Applied to mental health, this means conversational warmth should not be treated as proof of clinical accuracy or confidentiality. Product evaluation should address harmful responses and data protection as well as symptom improvement. [WHO guidance on generative AI in health](https://www.who.int/news/item/18-01-2024-who-releases-ai-ethics-and-governance-guidance-for-large-multi-modal-models).

Frequently Asked Questions

No. It describes a difference on a standardized statistical scale, not a percentage improvement or the proportion who recovered.

An app may support care, but replacement requires evidence about the particular product and clinical situation. NIMH highlights unresolved questions about effectiveness compared with in-person treatment.

It may deliver related exercises, but clinician-delivered psychotherapy includes an ongoing therapeutic relationship and treatment tailored to the person's needs. Sharing a treatment label does not make the services equivalent.

Do not assume they are. Check the provider's policies on storage, access and sharing before entering sensitive information. WHO identifies data protection as a central concern for health-related AI.

Contact a qualified health professional and use the app's support or escalation options. In an immediate crisis, seek local emergency or crisis services rather than relying on an automated conversation.

References

  1. Mokhtari Masoumi Alamdarloo, S., et al. [Effectiveness of AI and rule-based conversational agents for depression, anxiety and stress: A meta-analysis](https://www.nature.com/articles/s41746-026-02820-1). npj Digital Medicine. 2026;9:650.
  2. National Institute of Mental Health. [Psychotherapies](https://www.nimh.nih.gov/health/topics/psychotherapies).
  3. National Institute of Mental Health. [Technology and the Future of Mental Health Treatment](https://www.nimh.nih.gov/health/topics/technology-and-the-future-of-mental-health-treatment).
  4. World Health Organization. [WHO releases AI ethics and governance guidance for large multi-modal models](https://www.who.int/news/item/18-01-2024-who-releases-ai-ethics-and-governance-guidance-for-large-multi-modal-models). January 18, 2024.